Want to see JP:4320 full AI Analyst Report?
Top Page
CE Holdings Co., Ltd.
(4320)
Select Model
Select Model
Rating:67Neutral
Price Target:
¥1,798.00
▲(71.56% Upside)
Action:Downgraded
Date:08/19/26
The score is primarily supported by solid financial performance (improving profitability, low leverage, and stronger free cash flow), but tempered by near-term technical weakness (price below key short-term moving averages and negative MACD). Valuation is moderate with a modest dividend yield, offering some support but not enough to offset the softer momentum and recent revenue decline risk.
Positive Factors
Low Leverage and Stronger Capital Base
Modest leverage and a larger equity base improve financial flexibility and resilience. This gives CE Holdings greater capacity to fund operations, absorb business volatility, and pursue investment without excessive dependence on external borrowing.
Negative Factors
Sharp Most-Recent Revenue Decline
The latest revenue contraction weakens near-term growth visibility and raises questions about demand, customer activity, or project timing. Even with longer-term growth, sustained expansion will depend on restoring consistent top-line momentum.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage and Stronger Capital Base
Modest leverage and a larger equity base improve financial flexibility and resilience. This gives CE Holdings greater capacity to fund operations, absorb business volatility, and pursue investment without excessive dependence on external borrowing.
Read all positive factors
CE Holdings Co., Ltd. (4320) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥27.79B
Dividend Yield1.33%
Average Volume (3M)84.19K
Price to Earnings (P/E)17.3
Beta (1Y)0.67
Revenue Growth5.30%
EPS Growth52.48%
CountryJP
Employees443
SectorGeneral
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)95.40
Shares Outstanding17,039,400
10 Day Avg. Volume92,620
30 Day Avg. Volume84,186
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.46
Price to Sales (P/S)0.76
P/FCF Ratio13.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CE Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
CE Holdings Co., Ltd., operating through its subsidiaries in Japan, specializes in the development and sale of electronic medical record (EMR) and comprehensive medical information systems. Its product portfolio includes MI RA Is (Miraize), a nota...
How the Company Makes Money
null...
CE Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
78
Positive
Cash Flow
74
Positive
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.80B | 15.83B | 14.55B | 13.63B | 13.70B | 12.28B |
| Gross Profit | 3.81B | 3.54B | 3.28B | 3.60B | 3.09B | 2.59B |
| EBITDA | 2.18B | 1.99B | 1.66B | 1.69B | 1.40B | 1.23B |
| Net Income | 1.59B | 1.56B | 123.42M | 687.53M | 588.00M | 632.93M |
Balance Sheet | ||||||
| Total Assets | 11.49B | 12.78B | 11.27B | 11.26B | 10.92B | 9.48B |
| Cash, Cash Equivalents and Short-Term Investments | 5.46B | 5.03B | 3.83B | 3.14B | 3.96B | 2.87B |
| Total Debt | 1.03B | 1.47B | 2.27B | 1.42B | 1.89B | 1.37B |
| Total Liabilities | 2.81B | 3.94B | 4.67B | 4.67B | 4.83B | 4.00B |
| Stockholders Equity | 8.16B | 8.30B | 6.10B | 6.08B | 5.63B | 5.07B |
Cash Flow | ||||||
| Free Cash Flow | 339.29M | 908.29M | 676.53M | 521.69M | 415.65M | 881.91M |
| Operating Cash Flow | 369.32M | 998.32M | 752.39M | 797.69M | 1.56B | 1.05B |
| Investing Cash Flow | 618.37M | 381.37M | -630.51M | -863.59M | -772.95M | -158.53M |
| Financing Cash Flow | 193.38M | -146.62M | 566.46M | -754.51M | 306.64M | -838.45M |
CE Holdings Co., Ltd. Technical Analysis
Neutral
1048.00
Price Trends
1719.72
Negative
1569.69
Positive
1343.05
Positive
Market Momentum
-14.50
Negative
40.84
Neutral
13.75
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4320, the sentiment is Neutral. The current price of 1048 is below the 20-day moving average (MA) of 1665.55, below the 50-day MA of 1719.72, and below the 200-day MA of 1343.05, indicating a neutral trend. The MACD of -14.50 indicates Negative momentum. The RSI at 40.84 is Neutral, neither overbought nor oversold. The STOCH value of 13.75 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4320.
CE Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥1.21T | 27.01 | 12.38% | 1.16% | 15.76% | 13.53% | |
71 Outperform | ¥224.48B | 33.04 | ― | 0.43% | 18.89% | 11.66% | |
67 Neutral | ¥27.79B | 17.30 | ― | 4.99% | 5.30% | 52.48% | |
59 Neutral | ¥87.96B | 45.14 | 6.35% | ― | 24.03% | 34.50% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
JP:4320
CE Holdings Co., Ltd.
1,650.00
921.15
126.38%
JP:2413
M3
1,855.00
-302.26
-14.01%
JP:4480
Medley
2,714.00
232.00
9.35%
JP:4483
JMDC Inc.
3,500.00
-641.85
-15.50%
JP:366A
Wellness Communications Corporation
1,190.00
-347.12
-22.58%
CE Holdings Co., Ltd. Corporate Events
CE Holdings lifts nine‑month profits but forecasts sharp full‑year earnings decline and scraps dividend
Aug 6, 2026
CE Holdings Co., Ltd. reported consolidated net sales of ¥13.29 billion for the nine months ended June 30, 2026, up 7.9% year on year, with operating profit rising 14.1% to ¥1.36 billion and profit attributable to owners of parent increa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.